George Kemble - Sep 7, 2023 Form 4 Insider Report for Sagimet Biosciences Inc. (SGMT)

Role
Executive Chairman, Director
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
Stock symbol
SGMT
Transactions as of
Sep 7, 2023
Transactions value $
$4,448
Form type
4
Date filed
9/8/2023, 04:15 PM
Previous filing
Jul 20, 2023
Next filing
Nov 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGMT Series A Common Stock Options Exercise $4.45K +5.63K $0.79* 5.63K Sep 7, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SGMT Stock Option (Right to Buy) Options Exercise $0 -5.63K -100% $0.00* 0 Sep 7, 2023 Series A Common Stock 5.63K $0.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested and exercisable as of the date hereof.